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INTRODUCTION
Neurons that synthesize and release gonadotropin-releasing hormone (GnRH) are central to the initiation and maintenance of reproductive function in vertebrates. Unlike most neurons in the brain, GnRH neurons do not originate within the central nervous system (CNS). In mammals (1, 2) , GnRH neurons first become detectable in the olfactory placode region and are thought to originate from this structure; recent work in zebrafish (3) suggests alternative extra-CNS origins for these cells that have yet to be explored in other species. Regardless of their initial origin, after fate specification, GnRH neurons leave their birthplace and subsequently migrate across the cribriform plate to enter the forebrain. Once migration ceases, GnRH neurons target their axons to the external zone of the median eminence (ME) for hormone release (4) . Regulation of GnRH neurons at the levels of initial birth and survival, subsequent migration and ultimate axon targeting is crucial, and disruption of any of these developmental phases may result in severe reproductive impairment.
As a first step toward the understanding of how the GnRH system forms, we need to gain insights into key regulatory factors that drive the development and promote the survival of GnRH neurons. Neurotrophic factors have traditionally been implicated in orchestrating a substantial share of these events in the central and peripheral nervous systems (5) . As much as neurotrophic factor research has flourished in the recent years, surprisingly little is known concerning the roles these multi-potent signaling molecules play in the formation and maintenance of the GnRH neuronal network. Studying how GnRH neuron development is regulated by neurotrophic factors is critical in gaining further knowledge with regard to the types of signals required to trigger changes in GnRH neuronal physiology.
Fibroblast growth factors (FGFs) are signaling molecules known to have profound neurotrophic effects on the developing nervous system (6) . Previously, we reported FGF-2, a 3 prototypic member of the FGF family, was highly neurotrophic in the immortalized GnRH neuronal cell lines, GT1 cells (7) . Recent studies on endogenous GnRH neurons revealed a subpopulation of GnRH neurons expressed FGF receptors (FGFRs; 8). Further, the addition of FGF-2 stimulated neurite outgrowth and the blockade of FGF signaling inhibited fate specification of primary GnRH neurons in culture (8) . The clinical relevance of these in vitro data was further strengthened by two recent reports indicating a causal relationship between the loss of function mutation in FGF receptor 1 (FGFR1) and Kallmann Syndrome, a pathology characterized by the complete or partial loss of GnRH function and anosmia (9, 10) . These results prompted the hypothesis that FGF signaling is critical for the proper formation and maintenance of a functional GnRH system.
To test this hypothesis, we investigated if the disruption of FGFR function in GnRH
neurons resulted in the abnormal formation of the GnRH system. We first tested if the overexpression of a dominant negative FGFR mutant (FGFRm; 11, 12) in GT1 cells, a GnRH neuronal cell line (13) , was effective in abolishing FGF responsiveness and altering the differentiative properties of these cells. Next, we generated transgenic mice in which the expression of the FGFRm was targeted to GnRH neurons to disrupt FGFR function in a cellspecific manner. We determined if GnRH neuron-specific disruption of FGFR function in these mice led to an aberrantly formed GnRH system and/or altered fertility. Together, these results enable us to determine if FGF signaling is critical, at the organismal level, for the establishment of a neuroendocrine system essential for vertebrate reproduction.
RESULTS

cDNA constructs
The components of the FGFRm cDNA, a truncated FGFR1, are illustrated in Fig. 1A .
This cDNA was used to generate CMV-FGFRm (Fig. 1B) for the transfection of the GT1 cells, and G-FGFRm (Fig. 1C) for the generation of transgenic mice. Details of plasmid construction are described in the Materials and Methods.
Transfected GT1-7 cells GT1-7 cells were stably transfected with CMV-FGFRm (see Fig. 1B ) to disrupt the function of endogenous FGFRs. Northern blot analysis using a randomly-primed (Fig. 2) . Since one of the clones (CMV-FGFRm-3) appeared to express the highest FGFRm to endogenous FGFR1 ratio, this clone was expanded and used for all subsequent biological studies.
CMV-FGFRm-3 cells exhibited very different cellular morphology compared to the CMV-null control cells (Figs. 3A, B) . CMV-null cells were elongated and extended neurites toward neighboring cells (Fig. 3A) . In contrast, neurite outgrowth was markedly attenuated in CMV-FGFR-3 cells, which appeared flattened and possessed few cellular processes (Fig. 3B) .
When CMV-null cells were cultured under a serum-deprived condition, FGF-2 at concentrations ranging from 0.1-1 ng/ml significantly enhanced cell survival. However, FGF-2 treatment had no effect on the survival of CMV-FGFRm-3 cells (Fig. 3C ).
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The disruption of downstream signaling pathway by FGFRm expression was investigated using an in-gel ERK assay (Fig. 4) . This assay estimated the ERK activity by measuring the ability of both p42 and p44 ERKs to phosphorylate a substrate, myelin basic protein, embedded within the gel. CMV-null cells responded to the addition of 1 ng/ml FGF-2 with a robust activation of both p42 and p44 ERKs. However, this activation was completely absent in CMVFGFRm-3 cells (Fig. 4) .
Analysis of transgene expression in the G-FGFRm mice
Two founder mice (Founders 1 and 5) with the transgene incorporated into the genome were generated by the pronuclear injection of G-FGFRm (see Fig. 1C ) into one-cell embryos. Both the G-FGFRm-1 and G-FGFRm-5 lines were initially fertile and were bred to homozygosity. To verify the transgene was expressed correctly, northern blot analysis was conducted on total RNA isolated from the forebrain, hindbrain, and the liver (a negative control; 14) of wild-type (WT) and G-FGFRm mice. Two endogenous FGFR1 transcripts, approximately 4.3 kb and 1.8 kb, were observed in RNA extracted from the hindbrain and forebrain of WT mice (Fig. 5A) . No FGFR1 transcripts were seen in the liver, a negative control (Fig. 5A) . In G-FGFRm-1 mice, in addition to the two endogenous FGFR1 transcripts (4.3 and 1.8 kb), a smaller FGFR1 transcript of approximately 1.5 kb was present only in the forebrain, where GnRH neurons reside (Fig.   5A ). This transcript corresponds to the size of the FGFRm observed in the transfected GT1 cells (Fig. 2) . The hindbrain RNA was devoid of the FGFRm transcript, consistent with targeting of the transgene to GnRH neurons. Again, the liver did not express any FGFR1 transcript (Fig.   5A ).
For G-FGFRm-5 animals, WT mice also expressed the 4.3 and 1.8 kb transcripts of endogenous FGFR1 (Fig. 5B) . However, G-FGFRm-5 mice expressed two FGFRm transcripts, one approximately 1.5 kb, and one 1 kb. The latter is likely a splice variant of the former. Both FGFRm transcripts were expressed in the forebrain and hindbrain, demonstrating a rather 6 promiscuous expression pattern that was not tissue-specific. Neither WT nor G-FGFRm-5 mice expressed FGFRm in the liver (Fig. 5B) . Since G-FGFRm-1 mice expressed the single correct FGFRm transcript, and its expression was restricted to the forebrain, subsequent expression and phenotypic analyses were conducted exclusively with these mice. A GnRH neuronal count revealed a significant reduction (P < 0.001) in the GnRH neuron number in G-FGFRm-1 mice compared to their age-matched controls (Fig. 7) . To see if this phenotype was expressed predominantly in one sex over the other, the group was broken down into males and females. WT males and females possessed 700-800 neurons, a number consistent with the range of GnRH neuron number previously reported for mice (2) . A decrease in GnRH neuron number was observed in both male and female G-FGFRm-1 mice compared to WT controls, although this difference was more pronounced in the males (P < 0.001 in males, P < 0.05 in females, Fig. 7 ). Representative photomicrographs showed that the difference between G-FGFRm-1 and WT male mice was visible at the level of the organum vasculosum of the lamina terminalis (OVLT; Figs. 8A, B) . Visually, there was also a small but noticeable decline in GnRH fiber density in the ME of the G-FGFRm-1 males (Figs. 8C, D) . To examine if the loss of GnRH neurons was brain region-specific, the distribution of GnRH neurons in WT and G-FGFRm-1 mice was analyzed in defined areas. The distribution of GnRH neurons was not significantly different between the G-FGFRm-1 and WT male mice ( Fig.   9 ). Both showed a typical pattern of GnRH neuron distribution, with fewer GnRH neurons anterior to the OVLT, an abrupt increase near the OVLT, and a gradual decrease posterior to OVLT (Fig. 9 ). The distribution patterns of GnRH neurons in female WT and G-FGFRm-1 mice were similar to males (data not shown).
Reproductive phenotype of G-FGFRm-1 mice
The observation that transgenic mice possessed fewer GnRH neurons suggest their fertility may be disrupted. To verify this, several reproductive parameters were examined in male and female WT and G-FGFRm-1 mice (Table 1) . In adult females, fertility (number of days required to produce one litter) and the duration of estrous cycle were not significantly different between the 8 WT and transgenic mice (Table 1) . However, the size of the first litter was significantly reduced in G-FGFRm-1 females, although this reduction was not apparent in the subsequent litters (data not shown). The age of the final litter production was also significantly younger in G-FGFRm-1 adult females (Table 1 ). In the 30-day-old peripubertal animals, vaginal opening was observed in 100% WT females but none of the G-FGFRm-1 females, indicating delayed puberty in the latter group (Table 1) . A trend towards reduced hypothalamic GnRH concentration was observed in these females, although this was not significant (Table 1) . Peripubertal G-FGFRm-1 males had significantly reduced gonadosomatic index (GSI; [g testes mass/g body mass] x 100) and hypothalamic GnRH concentrations compared to WT males (Table 1 ). In the peripubertal animals, serum LH levels did not differ significantly between WT and transgenic animals for either males or females (Table 1) .
DISCUSSION
Although a growing body of evidence suggests FGF signaling is involved in the neurotrophic regulation of GnRH neurons (7, 8, 15) , much of the focus was on the action of FGF at the cellular level using in vitro models. The overall consequence of disrupting FGF signaling in GnRH neurons has not been investigated at the level of the organism. In the current study, we employed a strategy in which the expression of FGFRm, verified to disrupt signaling in GnRH cell lines, was genetically targeted to GnRH neurons. Targeted expression of the FGFRm to GnRH neurons resulted in a 30% reduction in the GnRH neuronal population and adversely affected several reproductive parameters. These results provided evidence that FGF signaling is critical for the maintenance of the full GnRH neuronal population into adulthood and consequently, the maintenance of optimal reproductive performance throughout the reproductive life span.
The FGFRm is a truncated murine FGFR1 lacking the intracellular tyrosine kinase domain (16) . Upon ligand binding to the receptor, the truncated receptor forms nonfunctional heterodimers with the WT FGFRs 1, 2, and 3, thereby blocking the subsequent signaling pathway. The same FGFRm targeted by the keratin and surfactant C protein promoters was shown to disrupt FGFR functions in mouse skin and lung bud epithelia, respectively (16, 17) .
The expression of the FGFRm in GT1 cells abolished the ability of transfected cells to extend neurites and respond to FGF-2 with enhanced survival, both well-documented neurotrophic effects of FGFs (6) . The diminished neurite outgrowth in FGFRm-stably transfected GT1 cells was likely due to the blunted autocrine response to the endogenous FGF-2 produced at low levels in GT1 cells (7) . The loss of neuronal morphology in FGFRm-transfected cells also suggests basal levels of FGF signaling may be required for the maintenance of a neuronal phenotype.
Lastly, the results from in-gel ERK assay support the well-documented mechanism by which FGFRm abolishes signaling pathways downstream of FGFR activation (11) .
It is presently unclear if CMV-FGFRm cells secreted altered levels of GnRH in culture.
Voigt et al. (15) reported that FGF-2 did not significantly affect GnRH secretion in GT1 cells, suggesting FGF-2 was not involved in the acute regulation of hormone release. Interestingly, the same study also reported increased mRNA levels of prohormone convertase 2, a key enzyme G-FGFRm-1 mice exhibited an average of 30% reduction in the size of GnRH neuronal population, with the reduction being more prominent in males than females. Interestingly, we found that WT females had significantly fewer GnRH neurons ( Fig. 7 ; P < 0.05 by Student's ttest) than males. This particular sexual dimorphism has been reported in mice (20) and may have contributed to the sex difference in GnRH neuron reduction observed here. These results were also consistent with our observation that the reduction in hypothalamic GnRH concentrations was more pronounced in transgenic males than females (see Table 1 ). Although a modest reduction in GnRH fiber density was also observed in the ME of the G-FGFRm-1 mice, the ability of GnRH axons to target the ME did not appear grossly altered, as a large number of axons still reached the ME. We believe the reduced fiber density was primarily due to the reduction in the number of GnRH neurons. It is also possible that the disruption of FGFR function resulted in the diminished ability of GnRH neurons to branch axons, leading to decreased levels of fiber intensity. Our previous observation that FGF-2 significantly promoted neurite branching in cultures of primary GnRH neurons supports this possibility (8) .
The uniform reduction in the number of GnRH neurons in all brain regions of the GFGFRm-1 mice suggests the size of the original GnRH neuronal population that migrated into the forebrain may have been reduced. Several explanations could account for this reduction. We previously showed that FGF signaling was required for the specification of GnRH neuronal fate in the olfactory placode (8) . In the absence of an FGF signal, the majority of GnRH neurons failed to emerge from their birthplace. However, the expression of FGFRm in G-FGFRm-1 mice is coupled to the activation of the GnRH promoter, thus one would not expect FGFRm to be expressed and FGFR function disrupted until after GnRH neurons are fully specified. A more plausible explanation for the reduced GnRH neuronal population is that in the absence of FGF signaling, a subpopulation of GnRH neurons failed to survive. To date, few studies have investigated the survival of GnRH neurons following fate specification. The prevailing view was that 800 GnRH neurons were born in the olfactory placode, and all 800 GnRH neurons survived and developed normally to reach the forebrain. However, an observation made by Wu et al. (21) revealed that the GnRH neuronal population actually reached a total of 2000 at embryonic day (E)12.75. This number then declined to 1100 in postnatal animals, and to 800 in adults. This observation suggested that less than 50% of the original GnRH neuronal population survived to adulthood. Moreover, it underscored the importance of survival-enhancing factors in maintaining and determining the final number of GnRH neurons. FGF-2, a potent survival enhancing factor in GT1 cells (7; current study), may be critical in promoting the survival of GnRH neurons, especially during the developmental period when a large number of GnRH neurons vanished in the forebrain.
Despite the absence of approximately 30% of GnRH neurons in the forebrain of GFGFRm-1 mice, these animals were initially fertile. This observation is not surprising considering findings in the hypogonadal (hpg) mouse. The hpg mice harbored a deletion in the GnRH gene that resulted in the inability to synthesize the mature GnRH peptide. The successful transplantation of just 1-3 detectable GnRH neurons was effective in restoring their fertility (22) (23) (24) . Thus, although reduced, the number of GnRH neurons present in G-FGFRm-1 mice was clearly sufficient for maintaining reproduction under laboratory conditions. It is important to point out that although these animals reproduced, the level of reproductive activity was reduced compared to controls. In particular, the delayed puberty, a reduction in the size of the first litter, and early reproductive senescence were all clear signs that the function of the GnRH system at the beginning and the end of the reproductive life span has been markedly compromised.
One might question why serum LH levels in transgenic mice remained unchanged despite the reduced GnRH neuron number and content. A recent study (25) reported similar 13 observations in mice harboring a mutation in carboxypeptidase E and thus could not process GnRH normally. These mice had very low bioactive GnRH concentrations in the hypothalamus, displayed a number of reproductive defects, but had normal circulating LH. One way these animals compensated for low GnRH was by increasing pituitary sensitivity to GnRH (25) .
Another study on these mice reported similar reduction in thyrotropin-releasing hormone (TRH) due to processing defect, but again, the level of circulating thyrotropin (TSH) was normal (26) .
These results, together with ours, clearly demonstrated the ability of animals to develop pituitary-level compensatory mechanisms to cope with diminished levels of releasing hormones.
Our current study provides the first evidence, at the level of the organism, that FGF signaling is involved in the maintenance of GnRH neurons. The significant reduction in the number of GnRH neurons may reflect a decrease in the survival of GnRH neurons during development. Several explanations could account for why only 30% of GnRH neurons were affected. First, the extent of FGFR disruption may vary greatly among individual GnRH neurons depending on the ratio of FGFRm to WT FGFR expression. It has been speculated that the FGFRm would have to be expressed at levels five to ten times higher than the WT receptor to completely inhibit signaling (11) . Due to the heterogeneous nature of the GnRH neuronal population (27) (28) (29) (30) , the level of GnRH gene expression is likely to vary among cells.
Consequently, the number of FGFRm expressed per cell is likely to vary since the expression of 
MATERIALS AND METHODS
Animals
Control and transgenic mice were derived from the mating of C57BL/6J and DBA/2J mice, and their offspring. All mice were housed in the animal facility under a 12L:12D cycle and fed water and rodent chow ad libitum. All animal procedures complied with protocols approved by the Institutional Animal Care and Use Committee of the University of California at San Francisco and University of Colorado at Boulder.
Construction of plasmids
The details of the FGFRm cDNA were described previously (16) . Briefly, a 1.1 kb (Fig. 1B) .
For construction of a FGFRm transgene that would target GnRH neurons, a 2.3 kb fragment of the rat GnRH promoter/enhancer region (G) was inserted via an Xba I site upstream of the rabbit β-globin intron of the FGFRm expression construct. The GnRH promoter/enhancer region consists of a fragment from -2987 to -1172 appended to -441 to +104 and contains a 731 bp deletion (13) . This GnRH promoter/enhancer fragment was used successfully to target the expression of SV40 T antigen to mouse GnRH neurons for the generation of GT1 cells (13) . For the production of transgenic mice, the resulting plasmid was excised with Kpn I and Sal I to generate a transgenic fragment (G-FGFRm; Fig. 1C) 
Cell survival assay
The responsiveness of transfected cells to FGF-2 was examined using a cell survival assay described previously (7) . Briefly, transfected cells were serum-starved for 4 days in the absence or presence of various doses of recombinant human FGF-2 (Promega, Madison, WI).
Cells were trypsinized on Day 0 (before serum starvation) and Day 4, and counted with a hemocytometer. Percent cell survival was calculated by dividing the cell number at Day 4 by the cell number at Day 0.
In-gel extracellular-regulated kinase (ERK) assay
The ability of FGFRm to disrupt endogenous FGFR function, and thus downstream signaling events, was monitored in the transfected cells by the in-gel ERK assay described previously (40) . We examined the activity levels of p42 and p44 ERKs, both of which were robustly activated in GT1 cells by the administration of FGF-2 (7). Details of this assay were described elsewhere (7).
Generation and screening of transgenic mice
The G-FGFRm transgene was injected into fertilized one-cell embryos as described previously (13) . The F2 embryos were derived from the mating of C57BL/6J and DBA/2J mice. formamide/2X SSPE at 65 o C and reprobed for the presence of glyceraldehyde phosphate dehydrogenase (GAPDH), an internal loading control, using the same procedure.
In situ hybridization analysis of transgene expression in GnRH neurons
The specificity of the transgene expression was analyzed by in situ hybridization on adjacent 10
µm frozen serial coronal sections from four 2-month-old homozygous G-FGFRm and four 2-month-old WT mice. A detailed protocol for the in situ analysis was described previously (41) .
Briefly, a total of 9 pairs of adjacent sections through the POA were used for the evaluation of each animal. Sections were acetylated, dehydrated progressively, and hybridized overnight at Monitoring the reproductive function of female and male WT and transgenic mice
Reproductive function of adult WT and G-FGFRm females were assessed by four criteria: the length of the estrous cycle, the mean duration required for the production of one litter, the size of the first litter, and the age of the female when the final litter was produced. The length of the estrous cycle was assessed by vaginal smears obtained daily for two weeks on females between 3-4 months of age. To assess the average duration required to produce a litter, the number of litters produced by females (between 3-8 months of age) in the constant presence of a male was recorded and normalized for the duration. We retired the female breeders when they failed to produce litters for three months. Thus, the final litter was defined as the litter before the breeding female was retired. Pubertal onset was assessed by measuring the incidence of vaginal opening in 30-day-old females, and GSI in 30-day-old males.
Hormone measurements
Hypothalamic GnRH concentrations in WT and G-FGFRm males was measured by a GnRH radioimmunoassay (43) . Serum luteinizing hormone (LH) was measured by a sensitive sandwich immunoassay described previously (44) .
Statistical analysis
Differences among multiple groups were analyzed by the one-way analysis of variance (ANOVA) followed by the Tukey's post-hoc test. Difference between two groups was analyzed by the Student's t-test. Difference in percent animals with vaginal opening between WT and transgenic animals was analyzed by the Fisher's exact test. Differences were considered significant when P < 0.05.
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